Juying Q. Wei
No. 79, Qingchun Road
Hangzhou, 310006, China
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.
Journal: Annals of hematology
Published: December 02, 2025
Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China.
Journal: Annals of hematology
Published: October 27, 2025
Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?
Journal: Annals of hematology
Published: October 22, 2025
TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.
Journal: Annals of hematology
Published: October 07, 2025
Covalent Bruton's tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study.
Journal: iScience
Published: September 16, 2025
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26).
Journal: Blood cancer journal
Published: August 21, 2025
Venetoclax and Homoharringtonine-Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T-Cell Precursor Acute Lymphoblastic Leukemia.
Journal: MedComm
Published: July 09, 2025
Revealing tumor microenvironmental heterogeneity and prognostic value in angioimmunoblastic T-cell lymphoma via spatial transcriptome sequencing.
Journal: Cell death & disease
Published: January 16, 2025
IFN-γ promotes the progression of iMCD by activating inflammatory monocytes.
Journal: Blood
Published: November 14, 2024
Last Updated: 09/26/2026